CRB Group, a leader in sustainable engineering and consulting services, has been honored with the 2026 International Society for Pharmaceutical Engineering (ISPE) Facility of the Year Award in the Social Impact category. This award recognizes a state-of-the-art cell therapy manufacturing facility built for AstraZeneca in Rockville, Maryland, which is designed to deliver patient-specific therapies reliably. Each treatment produced at this facility is tailored for individual patients, making consistent operation crucial for successful outcomes. The facility is engineered for 100% operational uptime, minimizing the risk of any interruptions that could affect patient therapies. Additionally, it meets net-zero operational carbon objectives, showcasing how environmental sustainability can align with healthcare needs. Vahid Ownjazayeri, CEO of CRB Group, emphasized the importance of engineering decisions that prioritize patient impact from the outset. The project involved integrated services across architecture, engineering, and construction, demonstrating CRB's commitment to excellence in the life sciences sector.